Full View

Epidermal growth factor receptor tyrosine kinase inhibitors for central nervous system metastases from non‐small cell lung cancer

MS Ahluwalia, K Becker, BP Levy - The Oncologist, 2018 - academic.oup.com
Central nervous system (CNS) metastases are a common complication in patients with
epidermal growth factor receptor (EGFR)‐mutated non‐small cell lung cancer (NSCLC) …
被引用次数：49 相关文章

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non-Small Cell Lung Cancer

MS Ahluwalia, K Becker, BP Levy - The oncologist, 2018 - pubmed.ncbi.nlm.nih.gov
Central nervous system (CNS) metastases are a common complication in patients with
epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) …

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non-Small Cell Lung Cancer

MS Ahluwalia, K Becker, BP Levy - The Oncologist, 2018 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title/>< jats: p> Central nervous system
(CNS) metastases are a common complication in patients with epidermal growth factor …

[引用][C] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non‐Small Cell Lung Cancer

MS Ahluwalia, K Becker, BP Levy - Oncologist, 2018 - baptisthealth.elsevierpure.com
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System
Metastases from Non‐Small Cell Lung Cancer — Baptist Health South Florida's Research …

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non-Small Cell Lung Cancer.

MS Ahluwalia, K Becker, BP Levy - The Oncologist, 2018 - europepmc.org
Central nervous system (CNS) metastases are a common complication in patients with
epidermal growth factor receptor (EGFR)‐mutated non‐small cell lung cancer (NSCLC) …
[HTML] nih.gov

[HTML][HTML] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non‐Small Cell Lung Cancer

MS Ahluwalia, K Becker, BP Levy - The Oncologist, 2018 - ncbi.nlm.nih.gov
Central nervous system (CNS) metastases are a common complication in patients with
epidermal growth factor receptor (EGFR)‐mutated non‐small cell lung cancer (NSCLC) …

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non-Small Cell Lung Cancer

MS Ahluwalia, K Becker, BP Levy - Oncologist, 2018 - pure.johnshopkins.edu
Central nervous system (CNS) metastases are a common complication in patients with
epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) …

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non‐Small Cell Lung Cancer.

MS Ahluwalia, K Becker, BP Levy - Oncologist, 2018 - search.ebscohost.com
Central nervous system (CNS) metastases are a common complication in patients with
epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) …
[PDF] wiley.com

[PDF][PDF] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non‐Small Cell Lung Cancer

MS Ahluwalia, K Becker, BP Levy - The Oncologist, 2018 - Wiley Online Library
Central nervous system (CNS) metastases are a common complication in patients with
epidermal growth factor receptor (EGFR)‐mutated non‐small cell lung cancer (NSCLC) …

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non-Small Cell Lung Cancer.

MS Ahluwalia, K Becker, BP Levy - The Oncologist, 2018 - europepmc.org
Central nervous system (CNS) metastases are a common complication in patients with
epidermal growth factor receptor (EGFR)‐mutated non‐small cell lung cancer (NSCLC) …